- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.38 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x MN: MANGANESE (II) ION(Non-covalent)
- 8 x Y5V: 5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-2-(2-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
Y5V.3: 14 residues within 4Å:- Chain A: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.1, MN.2
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:A.40, A:Y.44, A:Y.44, A:I.58
- Hydrogen bonds: A:E.46, A:Y.131, A:Y.131
Y5V.10: 14 residues within 4Å:- Chain B: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.8, MN.9
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:A.40, B:Y.44, B:Y.44, B:I.58
- Hydrogen bonds: B:E.46, B:Y.131, B:Y.131
Y5V.17: 14 residues within 4Å:- Chain C: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.15, MN.16
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:A.40, C:Y.44, C:Y.44, C:I.58
- Hydrogen bonds: C:E.46, C:Y.131, C:Y.131
Y5V.24: 14 residues within 4Å:- Chain D: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.22, MN.23
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:A.40, D:Y.44, D:Y.44, D:I.58
- Hydrogen bonds: D:E.46, D:Y.131, D:Y.131
Y5V.31: 14 residues within 4Å:- Chain E: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.29, MN.30
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:A.40, E:Y.44, E:Y.44, E:I.58
- Hydrogen bonds: E:E.46, E:Y.131, E:Y.131
Y5V.38: 14 residues within 4Å:- Chain F: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.36, MN.37
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:A.40, F:Y.44, F:Y.44, F:I.58
- Hydrogen bonds: F:E.46, F:Y.131, F:Y.131
Y5V.45: 14 residues within 4Å:- Chain G: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.43, MN.44
7 PLIP interactions:7 interactions with chain G- Hydrophobic interactions: G:A.40, G:Y.44, G:Y.44, G:I.58
- Hydrogen bonds: G:E.46, G:Y.131, G:Y.131
Y5V.52: 14 residues within 4Å:- Chain H: A.40, M.41, Y.44, E.46, K.54, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.50, MN.51
9 PLIP interactions:9 interactions with chain H- Hydrophobic interactions: H:A.40, H:Y.44, H:Y.44, H:I.58
- Hydrogen bonds: H:E.46, H:E.81, H:D.109, H:Y.131, H:Y.131
- 8 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
QQ4.4: 5 residues within 4Å:- Chain A: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.66, A:F.66, A:I.79
QQ4.11: 5 residues within 4Å:- Chain B: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.66, B:F.66, B:I.79
QQ4.18: 5 residues within 4Å:- Chain C: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:F.66, C:F.66, C:I.79
QQ4.25: 5 residues within 4Å:- Chain D: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:F.66, D:F.66, D:I.79
QQ4.32: 5 residues within 4Å:- Chain E: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:F.66, E:F.66, E:I.79
QQ4.39: 5 residues within 4Å:- Chain F: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain F- Hydrophobic interactions: F:F.66, F:F.66, F:I.79
QQ4.46: 5 residues within 4Å:- Chain G: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain G- Hydrophobic interactions: G:F.66, G:F.66, G:I.79
QQ4.53: 5 residues within 4Å:- Chain H: M.32, F.66, I.79, E.81, G.82
3 PLIP interactions:3 interactions with chain H- Hydrophobic interactions: H:F.66, H:F.66, H:I.79
- 24 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.7: 5 residues within 4Å:- Chain A: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain B: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain B: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain C: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain C: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain C: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain D: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain D: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain D: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain E: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.34: 3 residues within 4Å:- Chain E: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.35: 5 residues within 4Å:- Chain E: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.40: 4 residues within 4Å:- Chain F: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.41: 3 residues within 4Å:- Chain F: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.42: 5 residues within 4Å:- Chain F: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.47: 4 residues within 4Å:- Chain G: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.48: 3 residues within 4Å:- Chain G: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.49: 5 residues within 4Å:- Chain G: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIPSO4.54: 4 residues within 4Å:- Chain H: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain H: Y.162, E.166, R.169
Ligand excluded by PLIPSO4.56: 5 residues within 4Å:- Chain H: I.50, E.51, T.52, N.53, K.54
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cuypers, M.G. et al., The crystal structure of wild type PA endonuclease (2009/H1N1/CALIFORNIA) in complex with SJ000988503. To Be Published
- Release Date
- 2022-05-25
- Peptides
- Polymerase acidic protein: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.38 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x MN: MANGANESE (II) ION(Non-covalent)
- 8 x Y5V: 5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-2-(2-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
- 8 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
- 24 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cuypers, M.G. et al., The crystal structure of wild type PA endonuclease (2009/H1N1/CALIFORNIA) in complex with SJ000988503. To Be Published
- Release Date
- 2022-05-25
- Peptides
- Polymerase acidic protein: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A